These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23033348)
21. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator? Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087 [TBL] [Abstract][Full Text] [Related]
22. Observational Multicenter Study of a Direct-to-CT Protocol for EMS-transported Patients with Suspected Stroke. Cone DC; Cooley C; Ferguson J; Harrell AJ; Luk JH; Martin-Gill C; Marquis SW; Pasichow S Prehosp Emerg Care; 2018; 22(1):1-6. PubMed ID: 28841085 [TBL] [Abstract][Full Text] [Related]
23. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World. Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371 [TBL] [Abstract][Full Text] [Related]
24. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017. Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047 [TBL] [Abstract][Full Text] [Related]
25. Stop Stroke: A Brief Report on Door-to-Needle Times and Performance After Implementing an Acute Care Coordination Medical Application and Implications to Emergency Medical Services. Dickson R; Nedelcut A; Nedelcut MM Prehosp Disaster Med; 2017 Jun; 32(3):343-347. PubMed ID: 28219452 [TBL] [Abstract][Full Text] [Related]
26. Reducing delay to stroke thrombolysis--lessons learnt from the Stroke 90 Project. Kendall J; Dutta D; Brown E Emerg Med J; 2015 Feb; 32(2):100-4. PubMed ID: 24064044 [TBL] [Abstract][Full Text] [Related]
33. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC; Sung SF; Ong CT; Wu CS; Su YH Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [TBL] [Abstract][Full Text] [Related]
34. Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care. Sauser Zachrison K; Levine DA; Fonarow GC; Bhatt DL; Cox M; Schulte P; Smith EE; Suter RE; Xian Y; Schwamm LH Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28283469 [TBL] [Abstract][Full Text] [Related]
35. Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke. Lin CB; Cox M; Olson DM; Britz GW; Constable M; Fonarow GC; Schwamm L; Peterson ED; Shah BR J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26201547 [TBL] [Abstract][Full Text] [Related]
36. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals. Adelman EE; Scott PA; Skolarus LE; Fox AK; Frederiksen SM; Meurer WJ J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):67-73. PubMed ID: 26419527 [TBL] [Abstract][Full Text] [Related]
37. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513 [TBL] [Abstract][Full Text] [Related]